These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30881142)

  • 1. Pulmonary hypertension occurring with diazoxide use in a preterm infant with hypoglycemia.
    Kylat RI
    Drug Healthc Patient Saf; 2019; 11():7-10. PubMed ID: 30881142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide.
    Demirel F; Unal S; Çetin II; Esen I; Arasli A
    J Pediatr Endocrinol Metab; 2011; 24(7-8):603-5. PubMed ID: 21932611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension.
    Newman-Lindsay S; Lakshminrusimha S; Sankaran D
    Children (Basel); 2022 Dec; 10(1):. PubMed ID: 36670556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.
    Herrera A; Vajravelu ME; Givler S; Mitteer L; Avitabile CM; Lord K; De León DD
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4365-4372. PubMed ID: 30247666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Insufficiency Caused by Diazoxide in a Premature Neonate with Congenital Hyperinsulinism.
    Okada S; Fukunaga S; Ohta H; Furuta T; Hirano R; Motonaga T; Ishikawa Y
    Neuropediatrics; 2020 Jun; 51(3):211-214. PubMed ID: 31777044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The danger of diazoxide in the neonatal intensive care unit.
    Desai J; Key L; Swindall A; Gaston K; Talati AJ
    Ther Adv Drug Saf; 2021; 12():20420986211011338. PubMed ID: 34046157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.
    Kane C; Lindley KJ; Johnson PR; James RF; Milla PJ; Aynsley-Green A; Dunne MJ
    J Clin Invest; 1997 Oct; 100(7):1888-93. PubMed ID: 9312191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.
    Timlin MR; Black AB; Delaney HM; Matos RI; Percival CS
    Pediatr Cardiol; 2017 Aug; 38(6):1247-1250. PubMed ID: 28642988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilatation of the ductus arteriosus by diazoxide in fetal and neonatal rats.
    Toyoshima K; Momma K; Ishii T; Nakanishi T
    Pediatr Int; 2017 Dec; 59(12):1246-1251. PubMed ID: 28901668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term diazoxide treatment in persistent hyperinsulinemic hypoglycemia of infancy: a patient report.
    Darendeliler F; Bundak R; Bas F; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 1997; 10(1):79-81. PubMed ID: 9364348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant.
    Ohnishi Y; Okada S; Yasudo H; Kimura S; Suzuki Y; Hasegawa S
    Int Heart J; 2020 Sep; 61(5):1084-1087. PubMed ID: 32921661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diazoxide-associated pulmonary hypertension in a patient with noncompaction cardiomyopathy.
    Sullivan RT; Tillman KA; Kindel SJ; Handler SS
    Pulm Circ; 2021; 11(1):2045894020987117. PubMed ID: 33614015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of pulmonary hypertension in an infant treated with diazoxide.
    Nebesio TD; Hoover WC; Caldwell RL; Nitu ME; Eugster EA
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):939-44. PubMed ID: 17937066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged hyperinsulinemic hypoglycemia in a small for date preterm.
    Pezzati M; Barni S; Chiti G; Danesi G; Rubaltelli FF
    Minerva Pediatr; 2003 Feb; 55(1):79-82. PubMed ID: 12660630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of severe circulatory complications with diazoxide in premature infants.
    Yoshida K; Kawai M; Marumo C; Kanazawa H; Matsukura T; Kusuda S; Yorifuji T; Heike T
    Neonatology; 2014; 105(3):166-71. PubMed ID: 24458138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom.
    Chen SC; Dastamani A; Pintus D; Yau D; Aftab S; Bath L; Swinburne C; Hunter L; Giardini A; Christov G; Senniappan S; Banerjee I; Shaikh MG; Shah P
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):770-775. PubMed ID: 31520536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diazoxide improves hormonal counterregulatory responses to acute hypoglycemia in long-standing type 1 diabetes.
    George PS; Tavendale R; Palmer CN; McCrimmon RJ
    Diabetes; 2015 Jun; 64(6):2234-41. PubMed ID: 25591873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent neonatal hyperinsulinemic hypoglycemia in two siblings successfully treated with diazoxide.
    Wüthrich C; Schubiger G; Zuppinger K
    Helv Paediatr Acta; 1986 Dec; 41(5):455-9. PubMed ID: 3818333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of severe diazoxide toxicity.
    Silvani P; Camporesi A; Mandelli A; Wolfler A; Salvo I
    Paediatr Anaesth; 2004 Jul; 14(7):607-9. PubMed ID: 15200661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy.
    Yildizdas D; Erdem S; Küçükosmanoglu O; Yilmaz M; Yüksel B
    Adv Ther; 2008 May; 25(5):515-9. PubMed ID: 18512033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.